← Leaderboards
Howard J Huang
Washington University
$548,592
Attributed
$1,032,283
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $250K · FY2011–20$500K$375K$250K$125K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$1,032,283 · 2
By mechanism
R34$725,537 · 1
K08$306,746 · 1
Top collaborators
- Ramsey Hachem3 shared
- Kenneth B. Schechtman3 shared
Most similar at Washington University
Same institution · by research overlap
- Andrew Eric Gelman$12,797,349
- Thalachallour Mohanakumar$18,846,664
- Mario Castro$45,956,792
- Michael Jay Holtzman$55,932,256
- Stuart C Sweet$14,692,756
Others in their field
Top investigators on “Signal Transduction”
- Peter B. Gilbert · Fred Hutchinson Cancer Center$148,539,615
- David Heimbrook · Leidos Biomedical Research, Inc.$82,049,940
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$70,290,471
- Garret A Fitzgerald · University Of Pennsylvania$66,142,222
- Michael Barry Kastan · Duke University$64,512,357
- Randall J Bateman · Washington University$62,939,456
Research focus
Signal TransductionAllograftingMediatingTransplantationLung AllograftCessation Of LifeFunctional DisorderLung TransplantationRisk FactorsTransplant RecipientsPlayAntibodiesAcuteCell CycleCause Of DeathBaseCase StudyCareer DevelopmentAntigensAdherenceCytokineComparative EfficacyDesignCalcineurin Inhibitor
Grant awards (6)
A Pilot Randomized Controlled Trial of De Novo Belatacept-Based Immunosuppression in Lung Transplantation$237,979
R34 · FY2020 · HL
A Pilot Randomized Controlled Trial of De Novo Belatacept-Based Immunosuppression in Lung Transplantation$237,524
R34 · FY2019 · HL
A Pilot Randomized Controlled Trial of De Novo Belatacept-Based Immunosuppression in Lung Transplantation$250,034
R34 · FY2018 · HL
INNATE IMMUNE REGULATION OF PRIMARY GRAFT DYSFUNCTION$66,152
K08 · FY2013 · HL · contact PI
INNATE IMMUNE REGULATION OF PRIMARY GRAFT DYSFUNCTION$120,337
K08 · FY2012 · HL · contact PI
INNATE IMMUNE REGULATION OF PRIMARY GRAFT DYSFUNCTION$120,257
K08 · FY2011 · HL · contact PI